A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol

Keywords: Cilostazol,Probucol,Combination treatment,Atherosclerosis,Biomarkers,Synergetic effect

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text